UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prostate cancer screening： and yet it moves

Asian journal of andrology, 2015-05, Vol.17 (3), p.437-438

2015

Volltextzugriff (PDF)

Screening and Prostate-Cancer Mortality in a Randomized European Study

The New England journal of medicine, 2009-03, Vol.360 (13), p.1320-1328

2009

Volltextzugriff (PDF)

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

The Lancet (British edition), 2014-12, Vol.384 (9959), p.2027-2035

2014

Volltextzugriff (PDF)

Prostate-Cancer Mortality at 11 Years of Follow-up

The New England journal of medicine, 2012-03, Vol.366 (11), p.981-990

2012

Volltextzugriff (PDF)

Facilitated PCI in Patients with ST-Elevation Myocardial Infarction

The New England journal of medicine, 2008-05, Vol.358 (21), p.2205-2217

2008

Volltextzugriff (PDF)

A positive family history as a risk factor for prostate cancer in a population‐based study with organised prostate‐specific antigen screening: results of the Swiss European Randomised Study of Screening for Prostate Cancer (ERSPC, Aarau)

BJU international, 2016-04, Vol.117 (4), p.576-583

2016

Volltextzugriff (PDF)

A “PSA Pyramid” for Men with Initial Prostate-specific Antigen ≤3 ng/ml: A Plea for Individualized Prostate Cancer Screening

European urology, 2015-10, Vol.68 (4), p.591-597

2015

Volltextzugriff (PDF)

Smart Multi-Frequency Bioelectrical Impedance Spectrometer for BIA and BIVA Applications

IEEE transactions on biomedical circuits and systems, 2016-08, Vol.10 (4), p.912-919

2016

Volltextzugriff (PDF)

Comment on the US Preventive Services Task Force's Draft Recommendation on Screening for Prostate Cancer

European urology, 2012-04, Vol.61 (4), p.851-854

2012

Volltextzugriff (PDF)

Quantitative DNA methylation analysis of genes coding for kallikrein-related peptidases 6 and 10 as biomarkers for prostate cancer

Epigenetics, 2012-09, Vol.7 (9), p.1037-1045

2012

Volltextzugriff (PDF)

Pathological stage distribution in patients treated with radical prostatectomy reflecting the need for protocol‐based active surveillance: results from a contemporary European patient cohort

BJU international, 2012-07, Vol.110 (2), p.195-200

2012

Volltextzugriff (PDF)

Indication for Active Surveillance in the Era of MRI-Targeted Prostate Biopsies

Urologia internationalis, 2022-01, Vol.106 (1), p.83-89

2022

Volltextzugriff (PDF)

Is further screening of men with baseline PSA < 1 ng ml(-1) worthwhile? The discussion continues-Results of the Swiss ERSPC (Aarau)

International journal of cancer, 2015-08, Vol.137 (3), p.553-559

2015

Volltextzugriff (PDF)

Influence of metformin use on PSA values, free-to-total PSA, prostate cancer incidence and grade and overall survival in a prospective screening trial (ERSPC Aarau)

World journal of urology, 2015-08, Vol.33 (8), p.1189-1196

2015

Volltextzugriff (PDF)

Germline Mutations in the Kallikrein 6 Region and Predisposition for Aggressive Prostate Cancer

JNCI : Journal of the National Cancer Institute, 2017-04, Vol.109 (4)

2017

Volltextzugriff (PDF)

Outcomes following implantation of the biolimus A9-eluting BioMatrix coronary stent: Primary analysis of the e-BioMatrix registry

Catheterization and cardiovascular interventions, 2015-12, Vol.86 (7), p.1151-1160

2015

Volltextzugriff (PDF)

Protocol-based Active Surveillance for Low-risk Prostate Cancer: Anxiety Levels in Both Men and Their Partners

Urology (Ridgewood, N.J.), 2012-09, Vol.80 (3), p.564-569

2012

Volltextzugriff (PDF)

1-year survival in a randomized trial of facilitated reperfusion: results from the FINESSE (Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events) trial

JACC. Cardiovascular interventions, 2009-10, Vol.2 (10), p.909

2009

Volltextzugriff (PDF)

Differences among Men on Active Surveillance for Very Low-Risk Prostate Cancer Detected Through Population-Based versus Opportunistic Prostate-Specific Antigen-Screening

Urologia internationalis, 2015-01, Vol.94 (3), p.330-336

2015

Volltextzugriff (PDF)

In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic “gray zone” of total PSA 4 to 10 ng/mL

Urology (Ridgewood, N.J.), 1998-09, Vol.52 (3), p.360-365

1998

Volltextzugriff (PDF)

A comparative assessment of active surveillance for localized prostate cancer in the community versus tertiary care referral center

World journal of urology, 2014-08, Vol.32 (4), p.891-897

2014

Volltextzugriff (PDF)

Human glandular kallikrein as a tool to improve discrimination of poorly differentiated and non-organ-confined prostate cancer compared with prostate-specific antigen

Urology (Ridgewood, N.J.), 2000-04, Vol.55 (4), p.481-485

2000

Volltextzugriff (PDF)

A Multicenter Clinical Trial On the Use of Complexed Prostate Specific Antigen in Low Prostate Specific Antigen Concentrations

The Journal of urology, 2003-10, Vol.170 (4), p.1175-1179

2003

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library (Online service)

ThemaAged

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(27)

Sprache

Englisch
(27)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Prostate cancer screening： and yet it moves

Screening and Prostate-Cancer Mortality in a Randomized European Study

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

Prostate-Cancer Mortality at 11 Years of Follow-up

Facilitated PCI in Patients with ST-Elevation Myocardial Infarction

A positive family history as a risk factor for prostate cancer in a population‐based study with organised prostate‐specific antigen screening: results of the Swiss European Randomised Study of Screening for Prostate Cancer (ERSPC, Aarau)

A “PSA Pyramid” for Men with Initial Prostate-specific Antigen ≤3 ng/ml: A Plea for Individualized Prostate Cancer Screening

Relationship Between Baseline Prostate-specific Antigen on Cancer Detection and Prostate Cancer Death: Long-term Follow-up from the European Randomized Study of Screening for Prostate Cancer

Smart Multi-Frequency Bioelectrical Impedance Spectrometer for BIA and BIVA Applications

Prostate Cancer Mortality Reduction by Prostate-Specific Antigen–Based Screening Adjusted for Nonattendance and Contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)

Comment on the US Preventive Services Task Force's Draft Recommendation on Screening for Prostate Cancer

Quantitative DNA methylation analysis of genes coding for kallikrein-related peptidases 6 and 10 as biomarkers for prostate cancer

Pathological stage distribution in patients treated with radical prostatectomy reflecting the need for protocol‐based active surveillance: results from a contemporary European patient cohort

Indication for Active Surveillance in the Era of MRI-Targeted Prostate Biopsies

Is further screening of men with baseline PSA < 1 ng ml(-1) worthwhile? The discussion continues-Results of the Swiss ERSPC (Aarau)

Influence of metformin use on PSA values, free-to-total PSA, prostate cancer incidence and grade and overall survival in a prospective screening trial (ERSPC Aarau)

Germline Mutations in the Kallikrein 6 Region and Predisposition for Aggressive Prostate Cancer

Outcomes following implantation of the biolimus A9-eluting BioMatrix coronary stent: Primary analysis of the e-BioMatrix registry

Protocol-based Active Surveillance for Low-risk Prostate Cancer: Anxiety Levels in Both Men and Their Partners

1-year survival in a randomized trial of facilitated reperfusion: results from the FINESSE (Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events) trial

Differences among Men on Active Surveillance for Very Low-Risk Prostate Cancer Detected Through Population-Based versus Opportunistic Prostate-Specific Antigen-Screening

In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic “gray zone” of total PSA 4 to 10 ng/mL

A comparative assessment of active surveillance for localized prostate cancer in the community versus tertiary care referral center

Human glandular kallikrein as a tool to improve discrimination of poorly differentiated and non-organ-confined prostate cancer compared with prostate-specific antigen

A Multicenter Clinical Trial On the Use of Complexed Prostate Specific Antigen in Low Prostate Specific Antigen Concentrations

Aktive Filter

Suchergebnisse filtern